Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Transfer Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-pot method for Avibactam Sodium ensures high purity and safety. Reduces manufacturing complexity for pharmaceutical intermediate supply chains globally.
Novel catalytic route for posaconazole reduces impurities and cost. Reliable supply chain partner for high-purity antifungal API manufacturing.
Patent CN114437089A reveals a safer, high-yield route for Nalfurafine intermediate NAHY-2 using formic acid transfer hydrogenation, offering significant cost and supply chain advantages.
Patent CN113135831A reveals a safer 2-step synthesis for alminoprofen intermediates, eliminating Raney nickel risks and significantly reducing industrial waste generation.
Patent CN108676048B reveals a novel adenosine-based route for cordycepin. Achieve high purity and cost reduction in nucleoside manufacturing with scalable catalytic transfer hydrogenation.
Patent CN107522585B details a mild transfer hydrogenation method for quinoline resolution. Achieves 99% ee with organocatalysis, offering cost-effective and scalable chiral intermediate manufacturing.
Patent CN103073492A details a green Ru-catalyzed transfer hydrogenation for Montelukast intermediates, offering significant cost reduction and supply chain reliability.
Patent CN106146517A reveals safer tofacitinib citrate synthesis with improved yield and supply chain reliability for pharmaceutical manufacturing partners seeking cost reduction in API intermediate manufacturing processes globally.
Novel biomimetic catalytic transfer hydrogenation for aprepitant intermediates. High yield, mild conditions, cost-effective manufacturing solution.
Patent CN101215241A details a high-purity synthesis route for 1,4-bis(2,4-diaminophenoxy)benzene, offering cost reduction in polyimide manufacturing and reliable supply chain solutions.
Patent CN105481925A reveals a novel catalytic transfer hydrogenation route for high-purity Obeticholic Acid intermediates, ensuring supply chain reliability.
Novel atmospheric deprotection method for meropenem synthesis reduces equipment costs and improves yield. Reliable pharmaceutical intermediates supplier for scalable production.
Patent CN112094274A reveals a safer tofacitinib synthesis eliminating high-pressure hydrogen risks while controlling formylated impurities through precise alkaline hydrolysis.
Patent CN104710359A details a chiral phosphoric acid catalyzed route for high-purity tetrahydroquinolines, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Advanced preparation method for Valaciclovir Hydrochloride via transfer hydrogenation. Offers mild conditions, high purity, and significant cost reduction in pharmaceutical manufacturing.
Novel transfer hydrogenation method for chiral hydroxycyclobutenone. Offers high selectivity, mild conditions, and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN112174909B details a green method for aprepitant intermediates using biomimetic catalysts, offering high purity and scalability for pharma supply chains.
Patent CN116514707B reveals manganese-catalyzed asymmetric hydrogenation for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability.
Patent CN116514707B reveals manganese-catalyzed asymmetric hydrogenation for high-purity pharmaceutical intermediates, offering significant supply chain and cost advantages.
Patent CN109574797B reveals a green aqueous route for S-Int A. Achieve 99.9% ee and simplified purification for antifungal API manufacturing.